Literature DB >> 13786545

The treatment of severe staphylococcal infections with vancomycin.

D W WOODLEY, W H HALL.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS/therapy; STAPHYLOCOCCAL INFECTIONS/therapy

Mesh：

Substances：

Year:  1961        PMID： 13786545     DOI： 10.7326/0003-4819-55-2-235

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  13 in total

1.  In vitro activities of three semisynthetic amide derivatives of teicoplanin, MDL 62208, MDL 62211, and MDL 62873.

Authors:  F Biavasco; R Lupidi; P E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

Review 2.  Vancomycin- and erythromycin-induced hearing loss in humans.

Authors:  R E Brummett; K E Fox
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

3.  Mycobacterium avium-M. intracellulare and Acquired Immunodeficiency Syndrome.

Authors:  E Wolinsky; C R Horsburgh; D L Cohn; R B Roberts; H Masur; R Miller; A Y Tsang; M D Iseman
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

4.  Vancomycin Serum Concentration Monitoring : The Middle Ground is Best.

Authors:  F Marra; B Cairns; P Jewesson
Journal:  Clin Drug Investig       Date:  1996-08       Impact factor: 2.859

Review 5.  Diagnosis and management of methicillin resistant Staphylococcus aureus infection.

Authors:  G J Duckworth
Journal:  BMJ       Date:  1993-10-23

Review 6.  Vancomycin ototoxicity and nephrotoxicity. A review.

Authors:  G R Bailie; D Neal
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

Review 7.  Pharmacokinetic optimisation of vancomycin therapy.

Authors:  W G Leader; M H Chandler; M Castiglia
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

9.  Comparative antibacterial activity of Vancocin and generic vancomycin.

Authors:  J E Conte
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

10.  Vancomycin enhancement of experimental tobramycin nephrotoxicity.

Authors:  C A Wood; S J Kohlhepp; P W Kohnen; D C Houghton; D N Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.